Recro

Information

Recro(R) provides oral solid dosage form development, regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. Specializing in modified release oral solid dose and DEA controlled substances, Recro has the experts to deliver clients' most complex pharmaceutical development, manufacturing, and packaging projects in its best-in-class, 120,000-square-foot manufacturing facility. For more information about Recro's flexible CDMO solutions, visit www.recrocdmo.com.

Country

United States

Company Type

Manufacturer/Innovator

Exhibitor Access Type

In-Person & Online

Booth Location

2237

Offering

Offering: Markets Active in

OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)

Offering: Contract Services

Contract ManufacturingFormulation development

Offering: Custom Manufacturing

Custom Manufacturing of Dosage Form Drugs

Offering: Finished Dosage

CapsulesTablets

Offering: Pharmaceutical Packaging

Primary Packaging

Offering: Pharmaceutical Machinery & Technology

Drug Formulation (general category)Pharmaceutical Technology (general category)

Offering: Products or Services

Custom ManufacturingFinished Dosage FormsPharmaceutical PackagingContract ServicesPharmaceutical Machinery & Technology

Social media

Contact details

https://www.recrocdmo.com/